The structural modifications that extend its half-life also mean it accumulates in the body over time, which is why dose escalation protocols start low and increase gradually
Allocati N, Masulli M, Di Ilio C, Federici L (2018) Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
Assefa B, Mahmoud AM, Pfeiffer AFH, Birkenfeld AL, Spranger J, Arafat AM
doi:10.36849/JDD.8605
doi: 10.1111/jocd.15763
For condition-specific protocols, including ACL, Achilles, and rotator cuff dosing, see our upcoming article, BPC-157 Stacking and Injury Protocol Guide